"10.1371_journal.pone.0042677","none","2012-08-03T00:00:00Z","Tracy S P Heng; Jessica J Reiseger; Anne L Fletcher; Graham R Leggatt; Olivia J White; Katerina Vlahos; Ian H Frazer; Stephen J Turner; Richard L Boyd","Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, Victoria, Australia; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia; Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia","Conceived and designed the experiments: TH JR GL IF ST RB. Performed the experiments: TH JR AF GL OW KV. Analyzed the data: TH JR GL KV. Contributed reagents/materials/analysis tools: GL IF ST RB. Wrote the paper: TH JR AF. Reviewed the paper: TH JR AF GL OW KV IF ST RB.","This work was supported by Norwood Immunology Ltd, and a Pfizer Senior Research Fellowship to ST. RB is Chief Scientific Officer for Norwood Immunology, which licensed the technology for this study from Monash University (Patent WO/2002/030320: Stimulation of thymus for vaccination development; Publication Date 18.04.2002; International Filing Date 12.10.2001; this patent has since expired). None of the authors hold stock in this company. Rimadyl and Antidsedan, which are Pfizer products, were used in this study. There are no further patents, products in development, or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","08","Tracy S P Heng","TSPH",9,TRUE,6,6,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
